Business Description
Eiko Lifesciences Ltd
ISIN : INE666Q01016
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.35 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.19 | |||||
Interest Coverage | 7.54 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 15.82 | |||||
Beneish M-Score | -0.93 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.9 | |||||
3-Year EBITDA Growth Rate | -8 | |||||
3-Year EPS without NRI Growth Rate | -19.4 | |||||
3-Year FCF Growth Rate | -56.7 | |||||
3-Year Book Growth Rate | 8.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.07 | |||||
9-Day RSI | 53.36 | |||||
14-Day RSI | 53.26 | |||||
6-1 Month Momentum % | 14.51 | |||||
12-1 Month Momentum % | -5.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 10.04 | |||||
Quick Ratio | 9.13 | |||||
Cash Ratio | 1.05 | |||||
Days Inventory | 29.09 | |||||
Days Sales Outstanding | 133.76 | |||||
Days Payable | 19.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -46.5 | |||||
Shareholder Yield % | 0.04 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 8.97 | |||||
Operating Margin % | 2.48 | |||||
Net Margin % | 3.53 | |||||
FCF Margin % | -21.78 | |||||
ROE % | 2.6 | |||||
ROA % | 2.45 | |||||
ROIC % | 1.58 | |||||
ROC (Joel Greenblatt) % | 5.2 | |||||
ROCE % | 3.49 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 62.41 | |||||
PE Ratio without NRI | 59.36 | |||||
Shiller PE Ratio | 175.04 | |||||
PS Ratio | 2.25 | |||||
PB Ratio | 1.73 | |||||
Price-to-Tangible-Book | 1.74 | |||||
EV-to-EBIT | 52.7 | |||||
EV-to-EBITDA | 37.41 | |||||
EV-to-Revenue | 2.53 | |||||
EV-to-FCF | -11.34 | |||||
Price-to-Projected-FCF | 4.19 | |||||
Price-to-Graham-Number | 2.14 | |||||
Price-to-Net-Current-Asset-Value | 3.38 | |||||
Earnings Yield (Greenblatt) % | 1.9 | |||||
FCF Yield % | -8.33 | |||||
Forward Rate of Return (Yacktman) % | 20.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Eiko Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 340.961 | ||
EPS (TTM) (₹) | 1.03 | ||
Beta | -2.04 | ||
Volatility % | 48.34 | ||
14-Day RSI | 53.26 | ||
14-Day ATR (₹) | 4.468378 | ||
20-Day SMA (₹) | 62.177 | ||
12-1 Month Momentum % | -5.47 | ||
52-Week Range (₹) | 45.1 - 81.32 | ||
Shares Outstanding (Mil) | 13.86 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Eiko Lifesciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Eiko Lifesciences Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Eiko Lifesciences Ltd Frequently Asked Questions
What is Eiko Lifesciences Ltd(BOM:540204)'s stock price today?
When is next earnings date of Eiko Lifesciences Ltd(BOM:540204)?
Does Eiko Lifesciences Ltd(BOM:540204) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |